TScan Therapeutics (TCRX) Stock Chart & Stock Price History → Will this $2 AI stock double overnight? (From Behind the Markets) (Ad) Free TCRX Stock Alerts $7.38 +0.12 (+1.65%) (As of 04/24/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media TScan Therapeutics Stock Price Performance5 Day Performance+8.21%1 Month Performance-6.94%3 Month Performance+48.19%6 Month Performance+117.70%Year-To-Date Performance+26.59%1 Year Performance+196.39% Receive TCRX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for TScan Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad American AlternativeUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!The FEDNOW Biden Dollar ends cash in a matter of WEEKS Stumbling Biden's dollar next phases begins Oct 21st This guide shows you what to do next. In a cashless society, Biden forces you to use the government's new "digital dollar"...CLICK HERE TO GET YOUR GUIDE NOW TCRX Stock Chart for Thursday, April, 25, 2024 TCRX Chart by TradingView TScan Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/24/2024$7.26$7.38+1.65%$7.51$7.1189,303 shs$353.35 million04/23/2024$7.12$7.26+1.97%$7.55$7.02208,208 shs$347.61 million04/22/2024$6.82$7.12+4.40%$7.24$6.74173,211 shs$340.92 million04/19/2024$6.92$6.82-1.45%$7.13$6.71278,857 shs$326.54 million04/18/2024$6.75$6.92+2.52%$7.14$6.65250,511 shs$331.33 million04/17/2024$7.13$6.75-5.33%$7.36$6.581.64 million shs$323.19 million Get the Latest News and Ratings for TCRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for TScan Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/16/2024$7.69$7.13-7.28%$7.55$7.1298,718 shs$341.38 million04/15/2024$7.75$7.69-0.77%$7.92$7.44121,516 shs$368.20 million04/12/2024$7.80$7.75-0.64%$8.12$7.49128,926 shs$371.07 million04/11/2024$7.23$7.80+7.88%$7.87$7.21168,153 shs$373.46 million04/10/2024$7.45$7.23-2.95%$7.41$7.08131,547 shs$346.17 million04/09/2024$7.34$7.45+1.50%$7.82$7.3594,954 shs$356.71 million04/08/2024$7.09$7.34+3.53%$7.36$7.0370,509 shs$351.45 million04/05/2024$7.09$7.09$7.20$7.00105,837 shs$339.47 million04/04/2024$7.16$7.09-0.98%$7.33$6.98161,683 shs$339.48 million04/03/2024$7.20$7.16-0.56%$7.45$7.01125,111 shs$342.82 million04/02/2024$8.01$7.20-10.11%$7.99$7.14126,282 shs$344.74 million04/01/2024$7.94$8.01+0.88%$8.16$7.72121,823 shs$383.52 million03/29/2024$7.94$7.94$8.29$7.28741,662 shs$380.17 million03/28/2024$8.30$7.94-4.34%$8.27$7.28741,662 shs$380.17 million03/27/2024$7.99$8.30+3.88%$9.00$7.97448,974 shs$397.40 million03/26/2024$7.93$7.99+0.76%$8.24$7.91226,624 shs$382.56 million03/25/2024$8.02$7.93-1.12%$8.42$7.70397,286 shs$379.69 million03/22/2024$7.01$8.02+14.41%$8.06$7.17527,881 shs$384.00 million03/21/2024$7.01$7.01$7.09$6.8186,926 shs$335.64 million03/20/2024$6.97$7.01+0.57%$7.12$6.8886,651 shs$335.64 million03/19/2024$6.83$6.97+2.05%$7.19$6.6196,723 shs$333.74 million03/18/2024$7.12$6.83-4.07%$7.40$6.8193,403 shs$326.68 million03/15/2024$6.79$7.12+4.86%$7.12$6.56347,939 shs$340.55 million03/14/2024$6.71$6.79+1.19%$6.89$6.5593,537 shs$324.73 million03/13/2024$6.76$6.71-0.74%$7.09$6.4575,479 shs$320.94 million03/12/2024$6.56$6.76+3.05%$6.90$6.4365,790 shs$323.33 million03/11/2024$6.55$6.56+0.15%$6.88$6.4248,155 shs$313.77 million03/08/2024$7.14$6.55-8.26%$7.25$6.40157,969 shs$313.29 million03/07/2024$7.15$7.14-0.14%$7.35$6.98103,877 shs$341.51 million03/06/2024$7.03$7.15+1.71%$7.35$6.80139,354 shs$341.98 million03/05/2024$7.12$7.03-1.26%$7.17$6.7534,942 shs$336.21 million03/04/2024$7.20$7.12-1.11%$7.28$6.9497,560 shs$340.55 million03/01/2024$6.75$7.20+6.67%$7.67$6.77224,553 shs$344.38 million02/29/2024$6.71$6.75+0.60%$6.97$6.50139,876 shs$322.82 millionWill this $2 AI stock double overnight? (Ad)It's a tiny AI company fighting for a big piece of a $20 Billion Pentagon contract. What's more, this groundbreaking firm is trading for less than $2 a share!Click here to learn more >>>02/28/2024$6.45$6.71+4.03%$6.97$6.22342,141 shs$320.94 million02/27/2024$6.79$6.45-5.01%$6.79$6.15183,989 shs$308.50 million02/26/2024$6.76$6.79+0.44%$7.05$6.66123,721 shs$324.77 million02/23/2024$6.82$6.76-0.88%$6.78$6.40100,574 shs$323.33 million02/22/2024$6.95$6.82-1.87%$7.00$6.5273,795 shs$326.20 million02/21/2024$7.41$6.95-6.21%$7.31$6.74236,502 shs$332.42 million02/20/2024$6.78$7.41+9.29%$7.86$6.77727,170 shs$354.42 million02/19/2024$6.78$6.78$7.10$5.56655,700 shs$324.25 million02/16/2024$5.74$6.78+18.12%$7.10$5.56655,109 shs$324.29 million02/15/2024$5.80$5.74-1.03%$5.99$5.6077,078 shs$274.52 million02/14/2024$5.73$5.80+1.22%$5.89$5.6658,365 shs$277.41 million02/13/2024$5.94$5.73-3.54%$6.05$5.55132,294 shs$274.07 million02/12/2024$5.81$5.94+2.24%$6.02$5.44264,528 shs$284.11 million02/09/2024$6.00$5.81-3.17%$6.07$5.7092,870 shs$277.89 million02/08/2024$5.80$6.00+3.45%$6.05$5.66100,359 shs$286.98 million02/07/2024$5.92$5.80-2.03%$6.20$5.7487,851 shs$277.41 million02/06/2024$5.55$5.92+6.67%$6.02$5.56202,675 shs$283.15 million02/05/2024$5.24$5.55+5.92%$5.72$5.1194,390 shs$265.43 million02/02/2024$5.15$5.24+1.75%$5.25$4.9667,682 shs$250.63 million02/01/2024$5.11$5.15+0.78%$5.38$5.1135,821 shs$246.33 million01/31/2024$4.98$5.11+2.61%$5.24$4.81112,097 shs$244.39 million01/30/2024$5.24$4.98-4.96%$5.38$4.9541,259 shs$238.19 million01/29/2024$5.02$5.24+4.38%$5.33$4.9651,759 shs$250.63 million01/26/2024$4.98$5.02+0.80%$5.21$4.9761,886 shs$240.08 million01/25/2024$4.89$4.98+1.84%$5.05$4.6488,397 shs$238.19 million01/24/2024$5.04$4.89-2.98%$5.04$4.71111,592 shs$233.89 million Related Companies: Anavex Life Sciences Stock Chart MeiraGTx Stock Chart Tenaya Therapeutics Stock Chart SOPHiA GENETICS Stock Chart Aura Biosciences Stock Chart Invivyd Stock Chart Caribou Biosciences Stock Chart Jasper Therapeutics Stock Chart Humacyte Stock Chart Metagenomi Stock Chart Receive TCRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for TScan Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:TCRX) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyFed launches fourth dollar overhaulStansberry Research1970’s computer coder issues shocking A.I. warningTradeSmithExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersNew Trump BombshellThe Freeport SocietyMan Who Predicted 2008: “This Will be Worse.”Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TScan Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.